CYSTEINE RESIDUES IN THE VIF PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE ESSENTIAL FOR VIRAL INFECTIVITY

被引:58
|
作者
MA, XY
SOVA, P
CHAO, W
VOLSKY, DJ
机构
[1] ST LUKES ROOSEVELT HOSP,MOLEC VIROL LAB,NEW YORK,NY 10019
[2] COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032
关键词
D O I
10.1128/JVI.68.3.1714-1720.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The infectivity factor of human immunodeficiency virus type 1 (HIV-1), Vif, contains two cysteine residues which are highly conserved among animal lentiviruses. We introduced substitutions of leucine for cysteine residues in the vif gene of a full-length HIV-1 clone to analyze their roles in viral infection. Mutant viruses containing substitutions in either Cys-114, Cys-133, or both displayed a vif-negative infection phenotype similar to that of an isogeneic vif deletion mutant, namely, a cell-dependent complete to partial loss of infectivity. The vif defect could be complemented by cotransfection of mutant viral DNA with a Vif expression vector, and there was no evidence that recombination contributed to the repair of the vif deficiency. The viral protein profile, as determined by immunoblotting, in cells infected with cysteine substitution mutants and that in wild-type virus were similar, including the presence of the 23-kDa Vif polypeptide. In addition, immunoblotting with an antiserum directed against the carboxyl terminus of gp41 revealed that gp41 was intact in cells infected with either wild-type or vif mutant HIV-1, excluding that Vif cleaves the C terminus of gp41. Our results indicate that the cysteines in HIV-1 Vif are critical for Vif function in viral infectivity.
引用
收藏
页码:1714 / 1720
页数:7
相关论文
共 50 条
  • [31] THE MATRIX PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS REQUIRED FOR INCORPORATION OF VIRAL ENVELOPE PROTEIN INTO MATURE VIRIONS
    YU, XF
    YUAN, X
    MATSUDA, Z
    LEE, TH
    ESSEX, M
    JOURNAL OF VIROLOGY, 1992, 66 (08) : 4966 - 4971
  • [32] FUNCTIONAL DOMAINS OF THE CAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    DORFMAN, T
    BUKOVSKY, A
    OHAGEN, A
    HOGLUND, S
    GOTTLINGER, HG
    JOURNAL OF VIROLOGY, 1994, 68 (12) : 8180 - 8187
  • [33] ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    ALBINI, A
    BARILLARI, G
    BENELLI, R
    GALLO, RC
    ENSOLI, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) : 4838 - 4842
  • [34] TRANSCELLULAR TRANSACTIVATION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    HELLAND, DE
    WELLES, JL
    CAPUTO, A
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1991, 65 (08) : 4547 - 4549
  • [35] TRUNCATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN CYTOPLASMIC DOMAIN BLOCKS VIRUS INFECTIVITY
    DUBAY, JW
    ROBERTS, SJ
    HAHN, BH
    HUNTER, E
    JOURNAL OF VIROLOGY, 1992, 66 (11) : 6616 - 6625
  • [36] CONSERVATION OF AN INTACT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE IN-VITRO AND IN-VIVO
    SOVA, P
    VANRANST, M
    GUPTA, P
    BALACHANDRAN, R
    CHAO, W
    ITESCU, S
    MCKINLEY, G
    VOLSKY, DJ
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2557 - 2564
  • [37] ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES
    GABUZDA, DH
    LAWRENCE, K
    LANGHOFF, E
    TERWILLIGER, E
    DORFMAN, T
    HASELTINE, WA
    SODROSKI, J
    JOURNAL OF VIROLOGY, 1992, 66 (11) : 6489 - 6495
  • [38] MUTATIONAL ANALYSIS OF THE CONSERVED CYSTEINE-RICH REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    RICE, AP
    CARLOTTI, F
    JOURNAL OF VIROLOGY, 1990, 64 (04) : 1864 - 1868
  • [39] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [40] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366